| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 03/07/2013 | US20130059873 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-iv (dpp-iv) |
| 03/07/2013 | US20130059135 Printing composition and a printing method using the same |
| 03/06/2013 | EP2565886A1 Material for electrolytic solution, ionic material-containing composition and use thereof |
| 03/06/2013 | CN102958928A Dimeric SMAC Mimetics |
| 03/06/2013 | CN102952059A Amide derivative and preparation method thereof, medicine composition and application |
| 03/06/2013 | CN102952058A Maleimide ionic liquid, and preparation method and application thereof |
| 03/06/2013 | CN102952057A Preparation method of 4-isobutyl pyrrolidine-2-ketone |
| 03/06/2013 | CN102952056A Heptafluoroisopropylphenyl group contained diphenyl pyrroline compound and its use |
| 03/06/2013 | CN102952033A Novel compound, composing method thereof and therapeutic use therefor |
| 03/06/2013 | CN102166530B Bi-chiral organic small molecular catalyst and preparation method thereof |
| 03/05/2013 | US8389743 Histamine-3 receptor antagonists |
| 03/05/2013 | US8389742 3-hydrazino-2,5-dioxopyrrolidine-3-carboxylate, process for production of the same, and use of the same |
| 03/05/2013 | US8389741 Difluoroboradiazaindacene dyes |
| 03/05/2013 | US8389730 Compositions and methods for the treatment of disease associated with TRP-P8 expression |
| 03/05/2013 | US8389570 Hydroxamates as therapeutic agents |
| 03/05/2013 | US8389559 Pyrrolidine triple reuptake inhibitors |
| 02/28/2013 | WO2013027853A1 Ester production method |
| 02/28/2013 | WO2013026854A1 Sulfur-containing additives for electrochemical or optoelectronic devices |
| 02/28/2013 | US20130053577 Antiviral compounds |
| 02/28/2013 | US20130053572 Novel Cationic Lipids for Oligonucleotide Delivery |
| 02/28/2013 | US20130053417 Cetp activity inhibitors |
| 02/28/2013 | US20130053385 Method of combating and controlling pests |
| 02/28/2013 | US20130053344 Synthesis of pyrrolidine compounds |
| 02/28/2013 | US20130053342 Hydroxylated amide skin moisturizer |
| 02/28/2013 | US20130053315 Novel glp-1 derivatives |
| 02/28/2013 | US20130052237 Methods of Manufacturing Viscous Liquid Pharmaceutical Formulations |
| 02/28/2013 | US20130052130 Branched Discreet PEG Constructs |
| 02/27/2013 | EP2560952A1 Production of atorvastatin low in lactone impurities |
| 02/27/2013 | EP2560951A1 Production of atorvastatin low in ether impurities |
| 02/27/2013 | EP2560634A1 Nitric oxide releasing prodrugs of therapeutic agents |
| 02/27/2013 | EP2143444A9 Compositions for inhibition of angiogenesis |
| 02/27/2013 | CN102942482A Methods and compounds producing dipeptidyl peptidase iv inhibitors and intermediates thereof |
| 02/27/2013 | CN102153515B N,N'-bis-substituted urea Raf kinase inhibitors and preparation method and application thereof |
| 02/27/2013 | CN101918359B Sulfonamides as orexin antagonists |
| 02/27/2013 | CN101622229B Novel pyrrole derivative having ureido group and aminocarbonyl group as substituents |
| 02/26/2013 | US8383820 N-adamantyl benzamides as inhibitors of 11-β-hydroxysteroid dehydrogenase |
| 02/26/2013 | US8383669 Crystalline form of a 3-phenoxymethylpyrrolidine compound |
| 02/26/2013 | US8383668 11-beta-hydroxysteroid dehydrogenase type 1 active compounds |
| 02/26/2013 | US8383667 Forms of [R-(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid magnesium |
| 02/26/2013 | US8383666 Pyrrole derivatives, preparation of same and therapeutic application thereof |
| 02/21/2013 | WO2013025733A1 Lysophosphatidic acid receptor antagonists |
| 02/21/2013 | US20130046075 Process for gamma-butyrolactone production |
| 02/21/2013 | CA2844982A1 Lysophosphatidic acid receptor antagonists |
| 02/20/2013 | EP2558473A1 Method for producing dithiine tetracarboximides |
| 02/20/2013 | EP2558445A1 Intermediates useful for the synthesis of pyrrolobenzodiazepines |
| 02/20/2013 | EP2558444A1 Process for the preparation of pyrrolines from gamma-nitroketones. use of the gamma-nitroketones as pesticidal agents |
| 02/20/2013 | EP2558099A2 Kinase inhibitors |
| 02/20/2013 | CN102939294A Process for preparing dithiine-tetracarboxy-diimides |
| 02/20/2013 | CN102939288A Process for the preparation of dihydropyrrole derivatives |
| 02/20/2013 | CN102939281A Process for the preparation of glycopyrronium chloride |
| 02/20/2013 | CN102939280A Crystal form of glycopyrronium chloride |
| 02/20/2013 | CN102936218A Synthesis method of cis-3-amino-2-arylpyrrolidine derivative |
| 02/20/2013 | CN102161656B Aspartic acid-specific caspase inhibitors and uses thereof |
| 02/20/2013 | CN101300220B Hydrogen-catalysed process for preparing (meth)acrylates of n-hydroxyalkylated lactams |
| 02/19/2013 | US8378137 Synthesis of acyloxyalkyl carbamate prodrugs and intermediates thereof |
| 02/19/2013 | US8378121 Quaternary ammonium diphenylmethyl compounds useful as muscarinic receptor antagonists |
| 02/19/2013 | US8378099 Boronic ester and acid compounds, synthesis and uses |
| 02/19/2013 | US8377984 Substituted gamma lactams as therapeutic agents |
| 02/19/2013 | US8377974 Factor Xa inhibitors |
| 02/14/2013 | WO2013022047A1 Cyclopropaneamine compound |
| 02/14/2013 | WO2013020440A1 Amide derivate, and preparation method therefor, pharmaceutical composition and use thereof |
| 02/14/2013 | WO2013020391A1 (s)-4-hydroxy-2-oxo-1-pyrrolidineacetamide racemate crystal form ii and preparation method therefor |
| 02/14/2013 | WO2013020390A1 4-hydroxy-2-oxo-1-pyrrolidineacetamide racemate crystal form i and preparation method therefor |
| 02/14/2013 | WO2013020389A1 Method for purifying levo-oxiracetam |
| 02/14/2013 | WO2013020388A1 Method for purifying (s)-oxiracetam |
| 02/14/2013 | WO2012012278A3 Compositions and methods for the treatment of pathological condition(s) related to gpr35 and/or gpr35-herg complex |
| 02/14/2013 | US20130041163 Production of atorvastatin low in lactone impurities |
| 02/14/2013 | US20130041162 Production of atorvastatin low in ether impurities |
| 02/14/2013 | US20130041134 Methods for preparing polyethylene glycol maleimide using n-(2-hydroxyethyl) maleimide as a starting material |
| 02/14/2013 | US20130041106 Chemoselective enrichment for compound isolation |
| 02/14/2013 | US20130040998 Fluorinated hdac inhibitors and uses thereof |
| 02/14/2013 | US20130040935 Cyclic keto-enols for therapy |
| 02/14/2013 | US20130040932 Substituted aryl sulfone derivatives as calcium channel blockers |
| 02/14/2013 | US20130040884 Albumin-binding conjugates comprising fatty-acid and peg |
| 02/14/2013 | US20130040865 Succinimide compound, lubricating oil additive, and lubricating oil composition |
| 02/14/2013 | US20130037752 Electroluminescent materials comprising fluorene derivatives |
| 02/14/2013 | CA2844525A1 Cyclopropaneamine compound |
| 02/13/2013 | CN102933548A Carboxamide compounds and their use as calpain inhibitors |
| 02/13/2013 | CN102924412A 2-cyanophenyl sulfonamide derivatives useful as pesticides |
| 02/13/2013 | CN102924357A Preparation method for oxiracetam intermediate |
| 02/13/2013 | CN101296913B Heterocyclic amide derivatives useful as microbiocides |
| 02/13/2013 | CN101245043B Aza-heterocyclic compounds used to treat neurological disorders and hair loss |
| 02/13/2013 | CN101111493B 3-alkyl-5- (4-alkyl-5-oxo-tetrahydrofutran-2-yl) pyrrolidin-2-one derivatives as intermediates in the synthesis of renin inhibitors |
| 02/12/2013 | US8372985 Process of making α-aminooxyketone/α-aminooxyaldehyde and α-hydroxyketone/α-hydroxyaldehyde compounds and a process of making reaction products from cyclic α, β-unsaturated ketone substrates and nitroso substrates |
| 02/12/2013 | US8372982 Fungicidal N-(Phenylcycloalkyl)carboxamide, N-(Benzylcycloalkyl)carboxamide and thiocarboxamide derivatives |
| 02/12/2013 | US8372981 Nitrogen-containing aromatic derivatives |
| 02/12/2013 | US8372877 Stabilized statin formulations |
| 02/12/2013 | US8372840 Potassium channel blockers |
| 02/12/2013 | CA2539059C Novel ligand activating receptors rars used for human medicine and cosmetics |
| 02/07/2013 | WO2013018837A1 Left ventricular diastolic function improving agent |
| 02/07/2013 | WO2013017026A1 Hcv protease inhibitors |
| 02/07/2013 | US20130035635 Carrier-linked carbamate prodrug linkers |
| 02/07/2013 | US20130035484 Intermediates useful for the synthesis of pyrrolobenzodiazepines |
| 02/07/2013 | US20130035325 Kinase inhibitors |
| 02/07/2013 | US20130035322 Gold complexes |
| 02/07/2013 | US20130034738 Use of n-ethyl pyrrolidone in the production of electrodes for double-layer capacitors |
| 02/07/2013 | CA2842906A1 Left ventricular diastolic function improving agent |
| 02/06/2013 | EP2555274A1 Organic light emitting devices having carrier blocking layers comprising metal complexes |
| 02/06/2013 | EP2554538A1 Succinimide compound, lubricating oil additive, and lubricating oil composition |
| 02/06/2013 | EP2554533A1 Rare-earth metal complex |